Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation
An intracochlear cannula can deliver pharmaceutical interventions without causing additional hearing loss. L-NAC presents strong anti-apoptotic potential and administration through a cannula together with Dexel implantation, and achieves a synergistic effect enhancing the otoprotection.
Authors
- Adrien A. Eshraghi (ORCID: https://orcid.org/0000-0002-4083-905X)
- Roland Hessler (ORCID: https://orcid.org/0000-0002-0636-1128)
- Dario Ebode (ORCID: https://orcid.org/0000-0001-9248-0256)
- Carolyn Garnham
- Maria‐Pia Tuset (ORCID: https://orcid.org/0000-0001-5938-7236)
- Rahul Mittal (ORCID: https://orcid.org/0000-0003-0894-237X)
- S Schilp
- Teresa Melchionna
- Keelin McKenna (ORCID: https://orcid.org/0000-0002-0302-7036)
- Jeenu Mittal
- Jaimee Cooper (ORCID: https://orcid.org/0009-0001-3669-4775)
- Dimitri A. Godur
Institutions
- University of Miami (US)
- Cochlear (United States) (US)
- MED-EL (Austria) (AT)
- Neurological Surgery (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1002/ohn.1252
- Citations
- 1
- Primary Topic
- Hearing Loss and Rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 1.43